Atlantic Edge Private Wealth Management’s Novo Nordisk NVO Stock Holding History

Atlantic Edge Private Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.2K	Hold	275	–	–	﹤0.01%	389
2026 Q1	$10.1K	Sell	275 -50	-15%	-$2.37K	﹤0.01%	386
2025 Q4	$16.5K	Buy	325 +50	+18%	+$2.56K	﹤0.01%	328
2025 Q3	$15.3K	Sell	275 -200	-42%	-$11.7K	﹤0.01%	333
2025 Q2	$32.8K	Hold	475	–	–	0.01%	241
2025 Q1	$33K	Buy	475 +150	+46%	+$12.4K	0.01%	230
2024 Q4	$28K	Hold	325	–	–	0.01%	240
2024 Q3	$38.7K	Hold	325	–	–	0.01%	220
2024 Q2	$46.4K	Buy	325 +125	+63%	+$16.6K	0.02%	200
2024 Q1	$25.7K	Hold	200	–	–	0.01%	234
2023 Q4	$20.7K	Buy	+200	New	+$19.8K	0.01%	235

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Atlantic Edge Private Wealth Management's NVO Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 275 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #389.

Atlantic Edge Private Wealth Management first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $46.4K in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Atlantic Edge Private Wealth Management held 275 shares of Novo Nordisk worth $13.2K as of Q2 2026.
Atlantic Edge Private Wealth Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #389 holding.
Atlantic Edge Private Wealth Management first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
Atlantic Edge Private Wealth Management's Novo Nordisk position peaked at $46.4K in Q2 2024.
1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.